All Stories

  1. Patient attitudes toward and goals for MDD treatment: a survey study
  2. A systematic literature review identifying associations between outcomes and quality of life (QoL) or healthcare resource utilization (HCRU) in schizophrenia
  3. Results and validation of an index to measure health state of patients with depression in automated healthcare databases
  4. President Trump’s prescription to reduce drug prices: from the campaign trail to American Patients First
  5. From investigational product to active reference: evolution of oral sumatriptan efficacy versus placebo for the treatment of acute migraine episodes and potential impact in comparative analyses
  6. Systematic review of utility values used in the pharmacoeconomic evaluations for schizophrenia: implications on cost-effectiveness results
  7. Creation and validation of a linear index to measure the health state of patients with depression in automated healthcare databases
  8. Corrigendum to: Fall-related healthcare use and costs in neurogenic orthostatic hypotension with Parkinson’s disease
  9. Creating an index to measure health state of depressed patients in automated healthcare databases: the methodology
  10. A tolerability burden index in schizophrenia: incorporating patient perspective in clinical trial adverse event reporting